Showing results (1381-1390 of 1,920) with videos related to
Sort By:
Pageof 192
RMD Open|October 24, 2024
The mSQUASH is a feasible and valid measurement tool to uniformly assess daily physical activity in patients with rheumatic diseasesYvonne M van der Kraan, Lianne Gensler, Davy Paap, et al.RMD Open|October 8, 2024
Cardiovascular risk according to genetic predisposition to gout, lifestyle and metabolic health across prospective European and Korean cohortsKi Won Moon, Sang-Hyuk Jung, Hyunsue Do, et al.RMD Open|October 18, 2024
The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI studyGiulia Frazzei, Sophie H M Cramer, Robert B M Landewé, et al.RMD Open|August 20, 2024
Significant decrease of osteoporosis and osteoporotic fractures in rheumatoid arthritis within a period of 24 years: experiences of a single centrePeter Oelzner, Paul-Heinrich Mueller, Tobias Hoffmann, et al.RMD Open|August 20, 2024
Next-generation rheumatoid factor assay provides improved predictive power for the development of arthritis in patients at riskNienke Oskam, Pleuni Ooijevaar-de Heer, Dorien Kos, et al.RMD Open|October 22, 2024
Comparing outcomes of patients with early active rheumatoid arthritis initially treated on an inpatient or outpatient basis: a posthoc analysis of the CORRA trialAnna Mai, Dietmar Krause, Renate Klaassen-Mielke, et al.RMD Open|September 30, 2024
Change in different classes of chronic back pain suspicious of axial spondyloarthritis: a latent transition analysis of the SPACE cohortPhilipp Bosch, Alexandre Sepriano, Mary-Lucy Marques, et al.RMD Open|July 26, 2024
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohortClementina López-Medina, Anna Molto, Alexandre Sepriano, et al.RMD Open|May 13, 2025
Association of mitochondrial RNA expression levels in saliva and plasma with interferon signature gene expression and disease activity in patients with Sjögren diseaseYou-Jung Ha, Yong Seok Choi, Se Rim Choi, et al.RMD Open|May 11, 2025
Upadacitinib as monotherapy in patients with rheumatoid arthritis and prior inadequate response to methotrexate: results at 260 weeks from the SELECT-MONOTHERAPY randomised studyJosef S Smolen, Paul Emery, William Rigby, et al.Pageof 192